In the ever-evolving pharmaceutical industry landscape, the demand for high-throughput and robust endotoxin testing is key. Ensuring data integrity and regulatory compliance adds another layer of complexity. How can manufacturing companies successfully navigate these quality control challenges? 

Key insights: 

• With the increasing pace of pharmaceutical development and production, the need for high-throughput testing methods is undeniable.
• Maintaining data integrity is crucial for regulatory compliance and ensuring patient safety through the efficiency of pharmaceutical production.
• Integrated automated solutions ensure streamlined endotoxin testing processes while enhancing efficiency and accuracy.
• Partnering with industry-leading automation providers such as Tecan and bioMérieux allows access to tailored solutions for the specific needs of pharmaceutical quality control stakeholders.

Our unique automation solution, our state-of-the-art ENDOZYME^® II GO plates technology is combined with the industry expertise of the Tecan Fluent^® platform. We offer a comprehensive solution that empowers pharmaceutical companies to redefine their approach to endotoxin testing.

Key benefits: 

• Efficiency: Streamline testing processes and reduce turnaround times, allowing for faster decision-making and product release.
• Accuracy: Minimize the risk of human error and variability associated with manual testing methods, ensuring reliable results every time.
• Compliance: Meet stringent regulatory requirements with confidence, safeguarding product quality and patient safety.
• Cost savings: Simplify labor-intensive testing procedures, enabling lab personnel to focus on added-value tasks and critical analyses.

Ready to transform your endotoxin testing?
Explore how automation can revolutionize your pharmaceutical quality control programs.